Get all your news in one place.
100's of premium titles.
One app.
Start reading
WEKU
WEKU
Nurith Aizenman

How a scrappy African startup could forever change the world of vaccines

Imagine a world with vaccines not just for global threats like measles and COVID but for all the diseases that afflict people in the world's poorest countries – illnesses that are largely ignored but devastating, such as tuberculosis, dengue and lassa fever. And even for the ongoing epidemic of HIV.

Gerhardt Boukes, chief scientist at Afrigen Biologics and Vaccines, formulates mRNA for use in a new vaccine against COVID-19. The company — based in Cape Town, South Africa — is the linchpin of a global project to enable low- and middle-income countries to make mRNA vaccines against all manner of diseases. (Tommy Trenchard for NPR)

Better yet, what if these new vaccines were actually invented and manufactured in the very countries where they are most needed. These are countries currently so shut out of global vaccine production they were forced to wait last in line for COVID vaccines. Yet if and when the next pandemic hits these nations wouldn't just have access to new vaccines, they could be at the forefront of creating them.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.